Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by FUENTE, L. D. L.
Right arrow Articles by LARDELLI, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FUENTE, L. D. L.
Right arrow Articles by LARDELLI, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1994 Oxford University Press

other

Intravenous Administration among Heroin Users Having Treatment in Spain

LUIS DE LA FUENTE, GREGORIO BARRIO*, JULIÁN VICENTE*, MARIA J BRAVO* and PABLO LARDELLI{dagger}

Delegación del Gobierno para el Plan Nacional sobre Drogas and Departamento de Medicina Preventiva, Universidad de Granada
* Delegación del Gobierno para el Plan Nacional sobre Drogas, Ministerio de Sanidad y Consumo, Paseo del Prado 18–20, 28014 Madrid, Spain
{dagger} Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Granada Granada, Spain

BackgroundOf critical importance to AIDS control in Spain is the analysis of geographical variation and trend over time in the prevalence of intravenous administration in heroin users, as well as the factors associated with the use of this route.

MethodsWe carried out a cross-sectional study of 27 655 people admitted to outpatient treatment for heroin dependence in 15 of the 17 Autonomous Communities of Spain during 1991, using data provided by the State Information System on Drug Abuse (SEIT). To assess the association of some factors with use of the intravenous route crude and logistic analysis was performed.

ResultsThe prevalence of intravenous administration in this population was 64.4% with regional differences ranging between 33% and 90%. Crude and lcgistic analysis demonstrated a strong association with two factors in addition to geography: the year of first use and the age at first use (the earlier the first use, the greater the strength of the association).

ConclusionsThese findings are of paramount importance for the control of the HIV epidemic in Spain and further study in this area could help to guide policy development.

Received 1 January 1994


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Epidemiol. Community HealthHome page
L. de la Fuente, M. J. Bravo, C. Toro, M T. Brugal, G. Barrio, V. Soriano, F. Vallejo, R. Ballesta, and Project Itinere Group
Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.
J. Epidemiol. Community Health, June 1, 2006; 60(6): 537 - 542.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.